Clinical Trials Directory

Trials / Completed

CompletedNCT00274690

Post-Operative Nausea And Vomiting Study In Female Patients

A Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing With GW679769 (50 mg or 150 mg) for Three Consecutive Days When Administered With a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects With Known Risk Factors for Post-operative Nausea and Vomiting Who Are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated With an Increased Emetogenic Risk

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
435 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to determine an effective dose of this NK-1 anti-emetic medication to prevent nausea and vomiting in females after surgery.

Detailed description

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing with GW679769 (50 mg or 150 mg) for Three Consecutive Days When Administered with a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects with Known Risk Factors for Post-operative Nausea and Vomiting Who are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated with an Increased Emetogenic Risk

Conditions

Interventions

TypeNameDescription
DRUGGW679769

Timeline

Start date
2005-02-01
Primary completion
2005-08-01
Completion
2005-08-01
First posted
2006-01-11
Last updated
2017-01-20

Locations

44 sites across 11 countries: United States, Denmark, Hong Kong, Hungary, Israel, Norway, Philippines, Slovenia, Spain, Thailand, United Kingdom

Source: ClinicalTrials.gov record NCT00274690. Inclusion in this directory is not an endorsement.

Post-Operative Nausea And Vomiting Study In Female Patients (NCT00274690) · Clinical Trials Directory